World Bladder Cancer Patient Forum 2022

The World Bladder Cancer Patient Forum 2022, organised in partnership with Cancer Vessie France, will bring together leading voices in bladder cancer care, patient support and advocacy for the first time in-person and online on September 8, 2022.

Join us, our member organisations and key opinion leaders in Paris. It will host action-oriented conversations on addressing together the most challenging issues facing bladder cancer patients. Furthermore, learn from many initiatives from our communities that are positively impacting people affected by bladder cancer.

The latest Forum agenda is available here. We will be updating it as we confirm speakers so watch this space for future updates.

We invite you to join us and be part of the conversation about the way forward to improving the lives of bladder cancer patients all over the globe. Register today for the World Bladder Cancer Patient Forum 2022, taking place in Paris, France on September 8, 2022, at 14:30 CEST. The hybrid event will be available for participants to join online as well.

Registrations for the World Bladder Cancer Patient Forum 2022 are now open

In the lead-up to the Forum, we invite you to share the event with your colleagues. Start a conversation using the event hashtag #BladderCancerForum22 on social media.

We will be regularly updating this page with news regarding the upcoming Forum so watch this space!

We gratefully acknowledge the support of our Premier Partners Astellas, Bristol Myers Squibb, Seagen and Sponsors Roche, Merck and Pfizer for the World Bladder Cancer Patient Forum 2022.

Our past events

Each year we aim to build on the success of our previous events, learn from previous conversations and ensure that the quality of life of the people affected by bladder cancer improves.

If you are interested in exploring our past events and to better understand what drives us, then click below!

The first World Bladder Cancer Patient Forum took place virtually on September 22, bringing together over 150 registered attendees from 35 countries.

The Forum brought together leading voices from around the world. The panel discussed the role of patient voice from research design to treatment and care. The multi-stakeholder panel also explored the challenges of including patients’ voices in research design, bladder cancer care, and in driving policy change in areas concerning people affected by bladder cancer.

Our coalition member organisations have also showcased some of the activities they are leading. Many of which are having a positive impact on bladder cancer patients in their countries and communities.

Patient Forum 2021 image

At the WBCPC 2020 Virtual Annual Meeting, held in September we have brought together leaders in bladder cancer research, advocacy, patient organisations and the pharmaceutical industry. Participants from 25 countries worldwide have joined us to explore the topic: What action is needed to place bladder cancer higher on the global health policy agenda?

Strong bladder cancer patient groups across the world can bring bladder cancer higher on national and global health policy agenda, thus driving our collective mission towards ensuring the best possible outcomes for patients. One of the core missions of the World Bladder Cancer Patient Coalition is to foster an international community of people affected by bladder cancer.

We discussed different avenues for engaging our multi-stakeholder network to help us deliver this mission, exchange ideas on how to connect these communities with each other and with resources, and how to bring unity for the vision and goals of bladder cancer patient organisations worldwide.

The meeting will also brought attention to some of the most pressing issues in the bladder cancer community. From medicines shortages to innovation in bladder cancer, the discussion focused on patients voice in shaping research agenda and driving advocacy and policy change.


Have any questions?

We are always open to listening to the community for feedback, suggestions or potential collaborations, send us an email at:

You may be interested in